PROMIS NEUROSCIENCES INC. Common Stock, Capital Shares Reserved for Future Issuance
PROMIS NEUROSCIENCES INC. (PMN) had Common Stock, Capital Shares Reserved for Future Issuance of 10.79 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 10.79M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 9.71M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.90M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 72.80M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 10.79M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 9.71M shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 2.90M shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 72.80M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 63.68M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 63.68M shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 63.68M shares 10-Q · filed 2025-11-12 |
| 2024-09-30 | 63.88M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 18.35M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 18.42M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 16.13M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 16.56M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 4.38M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 4.48M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 4.48M shares 10-K · filed 2024-04-01 |
| 2022-09-30 | 4.07M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 3.75M shares 10-Q · filed 2022-08-12 |
| 2021-12-31 | 3.75M shares 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |